Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter? : Annals of Surgery

Journal Logo

Original Articles

Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma

Does Only a Complete Pathologic Response Matter?

Sihag, Smita MD*; Nobel, Tamar MD*; Hsu, Meier MS; De La Torre, Sergio*; Tan, Kay See PhD; Janjigian, Yelena Y. MD; Ku, Geoffrey Y. MD; Tang, Laura H. MD, PhD§; Wu, Abraham J. MD; Maron, Steven B. MD; Bains, Manjit S. MD*; Jones, David R. MD*; Molena, Daniela MD*

Author Information
Annals of Surgery 276(6):p 1017-1022, December 2022. | DOI: 10.1097/SLA.0000000000004638

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid